Related Experiment Video
Updated: Aug 4, 2025

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
Early Growth Response-1: Friend or Foe in the Heart?
Muntasir Billah1, Adiba Naz2, Rashed Noor3
1Department of Cardiology, Kolling Institute of Medical Research, Northern Sydney Local Health District, Sydney, NSW, Australia; Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.
Insights
Early growth response-1 (Egr-1) has a dual role in cardiovascular disease, acting as both a regulator and potentially offering protection. This review explores its complex functions in heart conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Gene Regulation
Background:
- Cardiovascular disease (CVD) is a leading global cause of death and illness.
- Early growth response-1 (Egr-1) is a key regulator in experimental CVD models.
- Egr-1 is induced by various cellular stressors relevant to cardiovascular pathology.
Purpose of the Study:
- To review and summarize the multifaceted roles of Egr-1 in cardiovascular pathobiology.
- To highlight the emerging understanding of Egr-1's cardioprotective potential.
- To provide a comprehensive overview of Egr-1's dual nature in cardiovascular disease.
Main Methods:
- Literature review of experimental and clinical studies on Egr-1 in cardiovascular disease.
- Analysis of molecular mechanisms underlying Egr-1 regulation and function.
- Synthesis of current research on the pro- and anti-pathogenic effects of Egr-1.
Main Results:
- Egr-1 exhibits complex regulatory functions in various cardiovascular disease models.
- Evidence suggests Egr-1 can mediate both detrimental and beneficial effects on the heart.
- Specific stimuli and cellular contexts dictate Egr-1's ultimate impact on cardiovascular health.
Conclusions:
- Egr-1 presents a dual role in cardiovascular pathobiology, with both damaging and protective aspects.
- Further research is warranted to fully elucidate Egr-1's therapeutic potential in cardiovascular diseases.
- Understanding Egr-1's complex functions is crucial for developing novel cardiovascular therapies.
Abstract:
Cardiovascular disease is a major cause of mortality and morbidity worldwide. Early growth response-1 (Egr-1) plays a critical regulatory role in a range of experimental models of cardiovascular diseases. Egr-1 is an immediate-early gene and is upregulated by various stimuli including shear stress, oxygen deprivation, oxidative stress and nutrient deprivation. However, recent research suggests a new, underexplored cardioprotective side of Egr-1. The main purpose of this review is to explore and summarise the dual nature of Egr-1 in cardiovascular pathobiology.
More Related Videos
Related Concept Videos
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Pathophysiology of Cardiac Performance

